Home › Ischemic Stroke › NCT02910180

Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* All patients diagnosed with cerebral vascular disease, regardless of gender, age, ethnicity/race, stage of disease or treatment, are eligible.
* Expected availability of clinical follow up data
* Participants must be willing to provide written, informed consent obtained in accordance with institutional and federal guidelines.

Exclusion Criteria:

* Pregnant women are excluded from the study.

About the study

This study encompasses the maintenance and utilization of a repository of samples from patients with cerebrovascular disease and stroke. The types of tissue taken are blood, cerebrospinal fluid (CSF), tissue, and microdialysis samples. Future analysis of these samples can potentially help investigators to better categorize groups of patients, understand the underlying etiology of these pathologies, identify markers that are associated with favorable or poor outcomes, and track changes that occur during the natural course of the disease or with treatment. This is a prospective observational study which will use samples from such patients to create this library which can be used to explore these questions in the future.

Sponsor: Cedars-Sinai Medical Center · Participants: 900 · Started: 2016-09

Contact the study team

• Nestor R Gonzalez, MD, MSCR · Phone: (310) 423-0783
• Patrick Lyden, MD · Phone: (310) 423-0894

Official record on ClinicalTrials.gov — NCT02910180

Locations in the U.S.

Conditions

• Ischemic Stroke
• Stroke
• Aneurysms
• Arteriovenous Malformations

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.